Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 21389792)

Published in Eur J Gastroenterol Hepatol on December 01, 2010

Authors

Julien Jézéquel1, Christophe Bessaguet, Cedric Verveur, Joseph Faycal, Zoe Richert, Jean-Philippe Metges, Alain Volant, Jean-Baptiste Nousbaum, Michel Robaszkiewicz

Author Affiliations

1: Department of Hepato-Gastroenterology, Brest University Hospital of Finistère, Brest, France. julien.jezequel@chu-brest.fr

Articles by these authors

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med (2011) 3.66

Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet (2002) 1.86

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements. J Nucl Med (2010) 1.55

Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study. J Clin Oncol (2005) 1.22

Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol (2005) 1.14

Retrospective study of 19 patients with intramedullary spinal cord metastasis. Clin Neurol Neurosurg (2008) 1.11

Crohn's disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol (2004) 1.11

Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol (2005) 1.08

Screening for esophagitis and Barrett's esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms. Am J Gastroenterol (2008) 1.05

Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol (2003) 1.05

Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies). J Steroid Biochem Mol Biol (2005) 1.02

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J Med Virol (2009) 1.02

Human caspase 7 is positively controlled by SREBP-1 and SREBP-2. Biochem J (2009) 0.97

Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study. Nucl Med Commun (2008) 0.96

Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease. Clin Gastroenterol Hepatol (2006) 0.95

Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol (2005) 0.93

Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg (2007) 0.93

Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective, nationwide survey. PLoS One (2013) 0.90

Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol (2007) 0.89

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. Gastroenterol Clin Biol (2004) 0.88

Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease. Dig Dis Sci (2008) 0.86

Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients. World J Hepatol (2013) 0.85

Advanced precancerous lesions in the lower oesophageal mucosa: high-grade dysplasia and intramucosal carcinoma in Barrett's oesophagus. Best Pract Res Clin Gastroenterol (2013) 0.83

Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82

[HER2 and gastric cancer. Recommendations for clinical practice in 2011]. Ann Pathol (2011) 0.81

VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer. Anticancer Res (2013) 0.81

Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol (2002) 0.80

Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Med Genet (2005) 0.80

Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients. J Hepatol (2003) 0.80

Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis (2012) 0.80

Management of rectal cancer in France in a well-defined population. Eur J Gastroenterol Hepatol (2014) 0.80

Validation of the short-form REFLUX-QUAL (RQS), a gastro-esophageal reflux disease (GERD) specific quality of life questionnaire. Gastroenterol Clin Biol (2005) 0.79

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infect Genet Evol (2011) 0.79

Computer-assisted diagnosis system in digestive endoscopy. IEEE Trans Inf Technol Biomed (2003) 0.79

Epidemiology of hepatocellular carcinoma in Finistère. Prospective study from June 2002 to May 2003. Gastroenterol Clin Biol (2007) 0.79

Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol (2009) 0.79

[Current trends in liver biopsy indications in chronic liver diseases]. Presse Med (2012) 0.78

Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study. PLoS One (2013) 0.78

[Is there still a need for liver biopsy in chronic hepatitis C?]. Gastroenterol Clin Biol (2002) 0.78

Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival. Pancreas (2016) 0.77

[Optimizing good use and costs of anticancer drugs: A French inter regional study of the Observatory of Cancer]. Bull Cancer (2013) 0.77

Paraneoplastic transient acantholytic dermatosis (Grover's disease) along Blaschko lines. Eur J Dermatol (2009) 0.77

[Are reagent strips useful for the diagnosis of spontaneous bacterial peritonitis?]. Gastroenterol Clin Biol (2006) 0.76

Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors. Eur J Gastroenterol Hepatol (2016) 0.76

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol (2017) 0.75

[Treatment of squamous cell carcinoma of the pancreas with gemcitabine]. Gastroenterol Clin Biol (2006) 0.75

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol (2017) 0.75

Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France. Eur J Gastroenterol Hepatol (2016) 0.75

[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)]. Bull Cancer (2007) 0.75

Benefit of antibiotic prophylaxis in cirrhotic patients with gastrointestinal bleeding in real life. Eur J Gastroenterol Hepatol (2015) 0.75

[Gastroesophageal reflux disease and malignancy]. Rev Prat (2008) 0.75

HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients. Ann Hematol (2015) 0.75